Ira Duarte Exercises Options at Heron Therapeutics Inc DE (HRTX) — SEC Form 4, Nov 03, 2026

SEC Form 4 · No Market Transaction
Option Exercise

Derivative exercise — no open market transaction.

Reporting Owner
Ira Duarte
CFO
TXN 2026-10-31 · FILED 2026-11-03
Equity Position 306K sh 287,998 → 306,051
Equity Change +6.3% shares held after vs before
Filing Lag 2 business days within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership

Heron Therapeutics Inc DE

HRTX CIK 0000818033
All Heron Therapeutics Inc DE insider activity
Filing Date
2026-11-03
Report Date
2026-11-03
Accession No.
0001193125-26-444847
Accepted At
2026-11-03 17:54 UTC
Reporting Owner
Name Relationship
Ira Duarte CIK 0001488864
CFO
Ira Duarte at Heron Therapeutics Inc DE Full insider history
Bought (12 mo) —
Sold (12 mo) —
More from this insider at Heron Therapeutics Inc DE
2026-10-21 Exercise — View
2026-08-03 Exercise — View
2026-07-20 Exercise — View
2026-06-17 Exercise — View
2026-05-04 Exercise — View
All filings by this insider at Heron Therapeutics Inc DE
Non-Derivative Securities Transactions
Title Date Type Shares Price Net Total Post-Txn Ownership
Common StockF1 2026-10-30 M - Exercise 13,535 A — 298,206 Direct
Common Stock 2026-10-30 F - Tax Payment 3,850 D $0.28 -$1,078 294,356 Direct
Common StockF1 2026-10-31 M - Exercise 11,695 A — 306,051 Direct
Common Stock 2026-10-31 F - Tax Payment 3,327 D $0.28 -$932 302,724 Direct
Derivative Securities Transactions
Title Strike Date Type Shares Price Expiration Underlying Ownership
Restricted Stock UnitsF3F3 $0.00 2026-10-31 M - Exercise 11,695 D $0.00 11,695 Common Stock Direct
Restricted Stock UnitsF2F2 $0.00 2026-10-30 M - Exercise 13,535 D $0.00 13,535 Common Stock Direct
Footnotes (3)
F1
Each restricted stock unit represents a contingent right to receive one share of common stock. Show more
F2
On January 30, 2026 (the "Date of Grant"), the Reporting Person was granted 216,562 RSUs which vest upon the following time-based vesting schedule: the RSUs vest in 16 equal quarterly installments beginning one quarter after the Date of Grant. Show more
F3
The restricted stock units vest in 16 equal installments beginning one quarter after the date of grant (January 31, 2025). Show more

Related filings at Heron Therapeutics Inc DE

Institutional Holders
13F holders · Jun 30, 2026 164 institutional managers reporting a position
Largest by reported value
  1. Rubric Capital Management Lp $12.8M
  2. Clearline Capital Lp $4.86M
  3. Black Rock, Inc. $4.5M
5%+ Holders · 13D/G 2 filers

Latest Schedule 13D/G per filer; stakes the filer reported closed are left out.

Other insiders at Heron Therapeutics Inc DE
All Heron Therapeutics Inc DE insider activity
GET /v1/forms/4/0001193125-26-444847 API docs
View Original SEC Filing